This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Jan 18;154(2):131-2.

doi: 10.7326/0003-4819-154-2-201101180-00303. Epub 2010 Dec 6.

Time for clinically relevant comparative effectiveness studies in type 2 diabetes

PMID: 21135287
DOI: 10.7326/0003-4819-154-2-201101180-00303

Free article

Editorial

Time for clinically relevant comparative effectiveness studies in type 2 diabetes

David M Nathan. Ann Intern Med. 2011.

Free article

. 2011 Jan 18;154(2):131-2.

doi: 10.7326/0003-4819-154-2-201101180-00303. Epub 2010 Dec 6.

Author

PMID: 21135287
DOI: 10.7326/0003-4819-154-2-201101180-00303

No abstract available

PubMed Disclaimer

Comment on

Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
Buse JB, Bergenstal RM, Glass LC, Heilmann CR, Lewis MS, Kwan AY, Hoogwerf BJ, Rosenstock J. Buse JB, et al. Ann Intern Med. 2011 Jan 18;154(2):103-12. doi: 10.7326/0003-4819-154-2-201101180-00300. Epub 2010 Dec 6. Ann Intern Med. 2011. PMID: 21138825 Clinical Trial.

Similar articles

Exenatide once weekly in type 2 diabetes.
Scheen AJ. Scheen AJ. Lancet. 2008 Oct 4;372(9645):1197-8. doi: 10.1016/S0140-6736(08)61207-6. Epub 2008 Sep 7. Lancet. 2008. PMID: 18782642 No abstract available.
Exenatide (Byetta) for type 2 diabetes.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2005 Jun 6;47(1210):45-6. Med Lett Drugs Ther. 2005. PMID: 15933616
[Exenatide convinces in a six-month study: HbA1c sunk significantly].
[No authors listed] [No authors listed] MMW Fortschr Med. 2009 May 7;151(19):51. MMW Fortschr Med. 2009. PMID: 19827448 German. No abstract available.
Clinical efficacy and safety of once-weekly glucagon-like peptide-1 agonists in development for treatment of type 2 diabetes mellitus in adults.
Tzefos M, Harris K, Brackett A. Tzefos M, et al. Ann Pharmacother. 2012 Jan;46(1):68-78. doi: 10.1345/aph.1Q379. Ann Pharmacother. 2012. PMID: 22232377 Review.
Beyond glycemic control: the role of incretin hormones.
Ridge TD. Ridge TD. J Am Acad Nurse Pract. 2007;19(11 Suppl 1):11-4. J Am Acad Nurse Pract. 2007. PMID: 18341243 Review. No abstract available.

See all similar articles

Cited by

Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.
DeVries JH, Bain SC, Rodbard HW, Seufert J, D'Alessio D, Thomsen AB, Zychma M, Rosenstock J; Liraglutide-Detemir Study Group. DeVries JH, et al. Diabetes Care. 2012 Jul;35(7):1446-54. doi: 10.2337/dc11-1928. Epub 2012 May 14. Diabetes Care. 2012. PMID: 22584132 Free PMC article. Clinical Trial.
The pragmatist's guide to comparative effectiveness research.
Chandra A, Jena AB, Skinner JS. Chandra A, et al. J Econ Perspect. 2011 Spring;25(2):27-46. doi: 10.1257/jep.25.2.27. J Econ Perspect. 2011. PMID: 21595324 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information